| abstract |
A method is provided for reducing a risk that a subject will experience a medically-related adverse event associated with inappropriate consumption of alcohol concurrent with the taking of a nonbenzodiazepine benzodiazepine receptor agonist (NBBRA). In an example, the method comprises administering to the subject a combination product that includes an effective amount of one or more NBBRAs, and an effective amount of one or more aldehyde dehydrogenase inhibitors (ALDIs), to provide the desired effects of the NBBRA in conjunction with a substance that prevents or deters concurrent alcohol consumption, thereby reducing the risk of the subject experiencing an alcohol-induced medically-related adverse event. Also disclosed are the combination products that include the effective amount of one or more NBBRAs and the effective amount of one or more ALDIs. |